Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #127406 on Biotech Values
biomaven0
09/27/11 10:39 AM
#127413 RE: pcrutch #127406
PolyMedix Initiates Phase 1B/2 Dose-Response Clinical Trial to Reverse the Anticoagulant Activity of Enoxaparin with PMX-60056